IDH2 and central nervous system cancer: Reuss et al. reported that 139 of 152 patients with diffuse astrocytoma diagnosed according to the WHO 2007 classification of the central nervous system tumors showed IDH mutant diffuse astrocytoma, whereas more than half of patients with diffuse astrocytoma were IDH wild-type in our cohort28.